Strides Pharma Science’s arm inks pact with Ennaid Therapeutics

15 Jun 2021 Evaluate

Strides Pharma Science’s step-down wholly-owned subsidiary -- Strides Pharma Global has entered into an exclusive partnership with US-based Ennaid Therapeutics to produce an oral medication to treat patients with mild and asymptomatic COVID-19. Partnership with Ennaid is part of company’s initiative to provide quality and affordable treatment to the global patient pool impacted by COVID-19.

Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.

Strides Pharma Scien Share Price

900.65 -39.00 (-4.15%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×